Results 81 to 90 of about 6,022,305 (300)

Identifying Patterns of Hospitalizations Among Childhood Cancer Survivors: A Population‐Based Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Childhood cancer survivors (CCSs) experience more hospitalizations than the general population. We aimed to identify distinct hospitalization patterns among Queensland CCSs and the associated characteristics. Methods Cases (aged ≤14 years) diagnosed between 1995 and 2019 while residents of Queensland were identified through the ...
Hai Pham, Teyl Engstrom, Peter Baade, Natalie Bradford, Sarah Pont, Louise Marquart‐Wilson, Natasha Nassar, Jason D. Pole   +7 more
wiley   +1 more source

Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care [PDF]

The United States aspires to use information from comparative effectiveness research (CER) to reduce waste and contain costs without instituting a formal rationing mechanism or compromising patient or physician autonomy with regard to treatment choices ...
Anirban Basu
core  

Comparative Effectiveness Trial Outcomes.

, 2015
δ negative number favors drug 1, positive number favors drug 2 in these comparisons.Comparative Effectiveness Trial Outcomes.
Jeffrey L. Jackson (147204), Rafael Santana-Davila (769651), Andrew Gradall (769654), Elizabeth Cogbill (769650), Jessica Kuester (769655), Christina Eldredge (769652), Neha Sehgal (326548), William Collier (769653)   +7 more
core   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga, Anne B. Verbeek, Caroline A. Lindemans, Emilie P. Buddingh   +3 more
wiley   +1 more source

The Pragmatist’s Guide to Comparative Effectiveness Research [PDF]

All developed countries have been struggling with a trend toward health care absorbing an ever-larger fraction of government and private budgets. Adopting any treatment that improves health outcomes, no matter what the cost, can worsen allocative ...
Jonathan S. Skinner, Amitabh Chandra, Anupam B. Jena   +2 more
core  

Secondary outcomes of comparative effectiveness trials.

, 2019
Secondary outcomes of comparative effectiveness trials.
Jeffrey L. Jackson (147204), Derek Storch (6490415), Sarah Nickoloff (6490412), Akira Kuriyama (147198), Zhi-Jiang Zhang (539386), Yasuaki Hayashino (19765), Yachiyo Kuwatsuka (688924), Wilkins Jackson (6490418)   +7 more
core   +1 more source

Regional Validation and Recalibration of Clinical Predictive Models for Patients With Acute Heart Failure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundHeart failure clinical practice guidelines recommend applying validated clinical predictive models (CPMs) to support decision making. While CPMs are now widely available, the generalizability of heart failure CPMs is largely unknown.
Benjamin S. Wessler, Robin Ruthazer, James E. Udelson, Mihai Gheorghiade, Faiez Zannad, Aldo Maggioni, Marvin A. Konstam, David M. Kent   +7 more
doaj   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine, Hallie Coltin, Maria Kondyli, Monia Marzouki, Nicolas Prud'homme, Nida Usmani, Rebecca J. Deyell, Lesleigh Abbott, Tony H. Truong, Sapna Oberoi, Ketan Kulkarni, Josée Brossard, Lynette Bowes, Paul Gibson, Sarah McKillop, Roona Sinha, Lillian Sung, Catherine Vezina, Laura Wheaton, Alexandra P. Zorzi, Marie‐Claude Pelland‐Marcotte, Thai Hoa Tran   +21 more
wiley   +1 more source

Impact of Initial Treatment Setting on Survival in Relapsed Pediatric and AYA Bone Sarcomas: A Secondary Analysis of a Prospective Clinical Trial

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak, Katarzyna Bilska, Tomasz Koziński, Jadwiga Węcławek‐Tompol, Dorota Sega‐Pondel, Radosław Chaber, Wanda Badowska, Katarzyna Rosłan, Hanna Koseła‐Paterczyk, Anna Raciborska   +9 more
wiley   +1 more source

Quality Assessment among comparative effectiveness trials.

, 2015
Quality Assessment among comparative effectiveness trials.
Jeffrey L. Jackson (147204), Rafael Santana-Davila (769651), Andrew Gradall (769654), Elizabeth Cogbill (769650), Jessica Kuester (769655), Christina Eldredge (769652), Neha Sehgal (326548), William Collier (769653)   +7 more
core   +1 more source